JP2024544415A5 - - Google Patents

Info

Publication number
JP2024544415A5
JP2024544415A5 JP2024537407A JP2024537407A JP2024544415A5 JP 2024544415 A5 JP2024544415 A5 JP 2024544415A5 JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024537407 A JP2024537407 A JP 2024537407A JP 2024544415 A5 JP2024544415 A5 JP 2024544415A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
approximately
formula
compound
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024537407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/087700 external-priority patent/WO2023118557A1/en
Publication of JP2024544415A publication Critical patent/JP2024544415A/ja
Publication of JP2024544415A5 publication Critical patent/JP2024544415A5/ja
Pending legal-status Critical Current

Links

JP2024537407A 2021-12-24 2022-12-23 動物における呼吸器疾患の治療のための注射用医薬組成物 Pending JP2024544415A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21217704 2021-12-24
EP21217704.2 2021-12-24
PCT/EP2022/087700 WO2023118557A1 (en) 2021-12-24 2022-12-23 An injectable pharmaceutical composition for the treatment of respiratory diseases in animals

Publications (2)

Publication Number Publication Date
JP2024544415A JP2024544415A (ja) 2024-11-29
JP2024544415A5 true JP2024544415A5 (cg-RX-API-DMAC7.html) 2026-01-05

Family

ID=79601675

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024537407A Pending JP2024544415A (ja) 2021-12-24 2022-12-23 動物における呼吸器疾患の治療のための注射用医薬組成物

Country Status (9)

Country Link
US (1) US20250057790A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452226A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024544415A (cg-RX-API-DMAC7.html)
CN (1) CN118632684A (cg-RX-API-DMAC7.html)
AR (1) AR128074A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022420882A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242451A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007862A (cg-RX-API-DMAC7.html)
WO (1) WO2023118557A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
AR134777A1 (es) 2023-12-21 2026-04-01 Intervet Int Bv Formas cristalinas de sales de (s)-n-(3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-((4-(((2-metoxietil)amino)metil)fenil)etinil)benzamida
CN122422289A (zh) 2023-12-21 2026-07-17 英特维特国际股份有限公司 (s)-n-(3-氨基-1-(羟基氨基)-3-甲基-1-氧代丁-2-基)-4-((4-(((2-甲氧基乙基)氨基)甲基)苯基)乙炔基)苯甲酰胺盐的结晶形式的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
JP7082445B2 (ja) 2016-12-23 2022-06-08 インターベット インターナショナル ベー. フェー. ウシ又はブタの呼吸器疾患を治療するための化合物

Similar Documents

Publication Publication Date Title
KR100752836B1 (ko) 분산성 약학 조성물
CN111295202B (zh) 治疗甲癣的外用制剂
US20030219472A1 (en) Compositions and method for transmucosal drug delivery and cryoprotection
CN1239427A (zh) Mupirocin在制备用于治疗与病原生物体鼻咽建群有关的细菌感染的药物中的应用
RU2018119295A (ru) Фармацевтические составы для местного применения для лечения связанных с воспалением состояний
JP5377326B2 (ja) ウシ類と他の動物における炎症を処置するための薬学的組成物および方法
KR102568082B1 (ko) 안과용 조성물
CN1700913A (zh) 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水成液制剂
CN105813651A (zh) 异噁唑啉组合物及其在预防或治疗动物的寄生虫侵袭中的用途
CA2728727C (en) Pharmaceutical transdermal compositions and method for treating inflammation in cattle
RU2016119746A (ru) Стабильный состав инсулина глулизин
JP2020011967A5 (cg-RX-API-DMAC7.html)
JP2010195823A (ja) 小動物用の注射可能な獣医用組成物
KR20110027838A (ko) 광선 각화증을 치료하기 위한 국소 조성물
JP2001513550A5 (cg-RX-API-DMAC7.html)
JPWO2003105841A1 (ja) 抗真菌医薬組成物
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
ES2617672T3 (es) Composiciones antihelmínticas de bencimidazol
RU2014129437A (ru) Офтальмологическая композиция
JP2022538505A5 (cg-RX-API-DMAC7.html)
EP4126057B1 (en) Composition having improved voluntary acceptance
RU2008147790A (ru) Фармацевтическая композиция на основе тилорона местного и наружного применения для лечения гнойно-деструктивных поражений слизистой и кожи, общесистемных заболеваний при иммунодефицитных состояниях
JP6128572B2 (ja) 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸を含有する水性液体組成物
RU2024120685A (ru) Инъекционная фармацевтическая композиция для лечения респираторных заболеваний у животных
JP2007519701A5 (cg-RX-API-DMAC7.html)